Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia

Overview

Journal Hematol Rep

Publisher MDPI

Date 2013 Jan 29

PMID 23355943

Authors

Natasha Ali

Salman Naseem Adil

Mohammad Usman Shaikh

Nehal Masood

Affiliations

Soon will be listed here.

Abstract

We report a case series of 12 patients with acute myeloid leukemia who underwent allogeneic stem cell transplant with a matched related donor. Male to female ratio was 1:1. The main complication post-transplant was graft-versus-host disease (n=7 patients). Transplant-related mortality involved one patient; cause of death was multi-organ failure. After a median follow up of 36.0±11.3 months, overall survival was 16%.

References

Sierra M, Alonso A, Odero M, Gonzalez M, Lahortiga I, Perez J . Geographic differences in the incidence of cytogenetic abnormalities of acute myelogenous leukemia (AML) in Spain. Leuk Res. 2006; 30(8):943-8. DOI: 10.1016/j.leukres.2005.12.025. View

Nakase K, Bradstock K, Sartor M, Gottlieb D, Byth K, Kita K . Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: a comparative study of Australian and Japanese adult cases. Leukemia. 2000; 14(1):163-8. DOI: 10.1038/sj.leu.2401638. View

Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A . EBMT activity survey 2004 and changes in disease indication over the past 15 years. Bone Marrow Transplant. 2006; 37(12):1069-85. DOI: 10.1038/sj.bmt.1705377. View

Appelbaum F, Gundacker H, Head D, Slovak M, Willman C, Godwin J . Age and acute myeloid leukemia. Blood. 2006; 107(9):3481-5. PMC: 1895766. DOI: 10.1182/blood-2005-09-3724. View

Koca E, Champlin R . Peripheral blood progenitor cell or bone marrow transplantation: controversy remains. Curr Opin Oncol. 2008; 20(2):220-6. DOI: 10.1097/CCO.0b013e3282f5100b. View

Kakepoto G, Burney I, Zaki S, Adil S, Khurshid M . Long-term outcomes of acute myeloid leukemia in adults in Pakistan. J Pak Med Assoc. 2003; 52(10):482-6. View

Weick J, Kopecky K, Appelbaum F, Head D, Kingsbury L, Balcerzak S . A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study. Blood. 1996; 88(8):2841-51. View

Michallet M, Thomas X, Vernant J, Kuentz M, Socie G, Milpied N . Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM). Bone Marrow Transplant. 2001; 26(11):1157-63. DOI: 10.1038/sj.bmt.1702690. View

BROWN R, Wolff S, Fay J, Pineiro L, Collins Jr R, Lynch J . High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group. Leuk Lymphoma. 1996; 22(3-4):271-7. DOI: 10.3109/10428199609051758. View

10.

Duval M, Klein J, He W, Cahn J, Cairo M, Camitta B . Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol. 2010; 28(23):3730-8. PMC: 2917308. DOI: 10.1200/JCO.2010.28.8852. View

11.

Mayer R, Davis R, Schiffer C, Berg D, Powell B, SCHULMAN P . Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med. 1994; 331(14):896-903. DOI: 10.1056/NEJM199410063311402. View

12.

Jourdan E, Boiron J, Dastugue N, Vey N, Marit G, Rigal-Huguet F . Early allogeneic stem-cell transplantation for young adults with acute myeloblastic leukemia in first complete remission: an intent-to-treat long-term analysis of the BGMT experience. J Clin Oncol. 2005; 23(30):7676-84. DOI: 10.1200/JCO.2005.02.5940. View

13.

Kataoka I, Kami M, Takahashi S, Kodera Y, Miyawaki S, Hirabayashi N . Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party. Bone Marrow Transplant. 2004; 34(8):711-9. DOI: 10.1038/sj.bmt.1704659. View

14.

Ullah K, Ahmed P, Raza S, Satti T, Chaudhry Q, Akhtar F . Management of acute myeloid leukaemia--5 years experience at Armed Forces Bone Marrow Transplant Centre, Rawalpindi. J Pak Med Assoc. 2007; 57(9):434-9. View

15.

Lowenberg B, Downing J, Burnett A . Acute myeloid leukemia. N Engl J Med. 1999; 341(14):1051-62. DOI: 10.1056/NEJM199909303411407. View

16.

Suciu S, Mandelli F, de Witte T, Zittoun R, Gallo E, Labar B . Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial. Blood. 2003; 102(4):1232-40. DOI: 10.1182/blood-2002-12-3714. View

17.

Ferrant A, Labopin M, Frassoni F, Prentice H, Cahn J, Blaise D . Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and.... Blood. 1997; 90(8):2931-8. View

18.

Shamsi T, Hashmi K, Adil S, Ahmad P, Irfan M, Raza S . The stem cell transplant program in Pakistan--the first decade. Bone Marrow Transplant. 2008; 42 Suppl 1:S114-S117. DOI: 10.1038/bmt.2008.137. View